Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02115


The primary purpose of this study is to provide treatment to patients who have participated on a prior protocol investigating Tanespimycin (KOS-953,17-AAG)


Inclusion Criteria: - Age >= 18 years - Participated in and completed a previous Tanespimycin protocol without evidence of unacceptable toxicity and is deemed by the Investigator to be deriving benefit from the Tanespimycin drug as defined in the previous protocol - All patients must rollover to this continuation protocol within 30 days of the last dose of Tanespimycin in the previous protocol, unless previously approved by the Medical Monitor - All Adverse Events from the prior protocol, must have resolved to NCI CTCAE (v. 3.0) Grade <= 2 - The following laboratory results, within 10 days of Tanespimycin administration: - Hemoglobin >= 8 g/dL - Absolute neutrophils count >= 1.0x 10*9* /L - Platelet count >= 50 x 10*9* /L - Serum bilirubin <= 2 x ULN - AST <= 2.5 ULN - Serum creatinine <= 2 x ULN - ECOG performance status of 0, 1 or 2 - Signed informed consent Exclusion Criteria: - Pre-existing neuropathy of CTCAE Grade >= 3 due to any cause - Documented hypersensitivity reaction of CTCAE Grade >= 3 to prior therapy containing Cremophor (for those patients receiving Tanespimycin Injection) - Pregnant or breast-feeding women - Administration of chemotherapy, biological, immunotherapy or investigational agent (therapeutic or diagnostic), excluding Tanespimycin within 21 days prior to receipt of study medication - Any medical conditions that, in the Investigator's opinion, would impose excessive risk to the patient



Primary Contact:

Study Director
Bristol-Myers Squibb
Bristol-Myers Squibb

Backup Contact:


Location Contact:

Boston, Massachusetts 02115
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.